- Home
- KALV vs AHG Comparison
KALV vs AHG Comparison
Compare KALV & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- AHG
- Stock Information
- Founded
- KALV N/A
- AHG 2013
- Country
- KALV United States
- AHG China
- Employees
- KALV N/A
- AHG N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- AHG Business Services
- Sector
- KALV Health Care
- AHG Consumer Discretionary
- Exchange
- KALV Nasdaq
- AHG Nasdaq
- Market Cap
- KALV 651.3M
- AHG 650.1M
- IPO Year
- KALV N/A
- AHG N/A
- Fundamental
- Price
- KALV $12.92
- AHG $1.54
- Analyst Decision
- KALV Strong Buy
- AHG
- Analyst Count
- KALV 8
- AHG 0
- Target Price
- KALV $24.83
- AHG N/A
- AVG Volume (30 Days)
- KALV 498.7K
- AHG 20.8K
- Earning Date
- KALV 07-10-2025
- AHG 06-06-2025
- Dividend Yield
- KALV N/A
- AHG N/A
- EPS Growth
- KALV N/A
- AHG N/A
- EPS
- KALV N/A
- AHG N/A
- Revenue
- KALV N/A
- AHG $8,454,946.00
- Revenue This Year
- KALV N/A
- AHG N/A
- Revenue Next Year
- KALV N/A
- AHG N/A
- P/E Ratio
- KALV N/A
- AHG N/A
- Revenue Growth
- KALV N/A
- AHG 281.19
- 52 Week Low
- KALV $7.30
- AHG $0.62
- 52 Week High
- KALV $15.50
- AHG $2.35
- Technical
- Relative Strength Index (RSI)
- KALV 60.56
- AHG 51.02
- Support Level
- KALV $11.11
- AHG $1.45
- Resistance Level
- KALV $11.93
- AHG $1.98
- Average True Range (ATR)
- KALV 0.60
- AHG 0.22
- MACD
- KALV 0.05
- AHG -0.02
- Stochastic Oscillator
- KALV 80.09
- AHG 22.81
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.